Shopping Cart
Remove All
Your shopping cart is currently empty
DuP-721 is a broad-spectrum, orally active antibacterial agent that inhibits a variety of clinically susceptible and resistant bacteria, particularly [M. tuberculosis].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | In Stock | In Stock | |
| 2 mg | $46 | In Stock | In Stock | |
| 5 mg | $77 | In Stock | In Stock | |
| 10 mg | $128 | In Stock | In Stock | |
| 25 mg | $263 | In Stock | In Stock | |
| 50 mg | $389 | In Stock | In Stock | |
| 100 mg | $556 | In Stock | In Stock | |
| 200 mg | $758 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $86 | In Stock | In Stock |
| Description | DuP-721 is a broad-spectrum, orally active antibacterial agent that inhibits a variety of clinically susceptible and resistant bacteria, particularly [M. tuberculosis]. |
| In vitro | DuP-721 (1.5-4 μg/ml) effectively inhibits both conventional antituberculosis drug-susceptible and -resistant Mycobacterium tuberculosis strains without showing cross-resistance to any tested anti-tuberculosis drugs[1]. It is ineffective against M. avium and M. intracellulare up to 250 μg/ml, but inhibits M. gordonoe and M. fortuitum at 3.9 μg/ml, and M. kansasii and M. scrofulaceum at 1.95 μg/ml and 15.6 μg/ml, respectively[1]. |
| In vivo | DuP-721, the first oxazolidinone showed good activity against M. tuberculosis when given orally or parenterally to experimental animals. DuP-721 (oral gavage; 50-160 mg/kg) is protective against M. tuberculosis infection in mice. DuP-721 protects 100% of the infected animals at 50 mg/kg p.o. dose when administered daily for 17 days, and the same effect is observed at 160 mg/kg dose when the drug is administered only on day 11 and 12 post infection[1]. |
| Molecular Weight | 276.29 |
| Formula | C14H16N2O4 |
| Cas No. | 104421-21-8 |
| Smiles | CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)C(C)=O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (354.70 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (14.48 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.